Immune Preconditioning with Oral Quercetin Supplement and COVID-19 mRNA Vaccine Responses: A Randomized, Double-Blind, Placebo-Controlled Trial.

What Was Tested

Researchers studied Copper (Supplement) in this randomized controlled trial publication.

This study examined the effects of quercetin glycoside (QG), a bioactive compound with anti-inflammatory and antiaging properties, taken before mRNA vaccination in older or metabolically at-risk individuals, focusing primarily on immune responses and secondarily on vaccine-related reactions.

Why It Was Studied

Several risk factors for severe outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccine responsiveness are related to aging and lifestyle-related conditions, like obesity-associated diabetes.

Who Took Part

By PubMed's age tags, the people studied were middle-aged adults and older adults, both men and women.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and parallel-group study.

The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

As a double-blind Copper (Supplement) study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Copper (Supplement) group a baseline to be compared against.

The Copper (Supplement) group and the comparison group ran side by side rather than switching.

Immune profiles were assessed for 3 mo post vaccination.

Linear mixed-effects models evaluated changes in antibody titers and antigen-specific T-cell activation, including group, time, and their interaction as fixed effects, with age, sex, and BMI as covariates.

What Was Measured

Several risk factors for severe outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccine responsiveness are related to aging and lifestyle-related conditions, like obesity-associated diabetes.

PubMed files the paper under topics including Quercetin, COVID-19, COVID-19 Vaccines, Dietary Supplements, SARS-CoV-2 and Antibodies, Viral.

The authors tagged it with the keywords aging, lifestyle-related diseases and vaccination.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Copper (Supplement).

Results are reported in around 10 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2026 (The Journal of nutrition), a journal based in United States.

More context: the Copper (Supplement) compound page, all human trials.